Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis-Reference-Cited by-同舟云学术

Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis

Published:2023-03 Issue:3 Volume:78 Page:584-595
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Nahon Pierre^ORCID,Bamba-Funck Jessica,Layese Richard^ORCID,Trépo Eric,Zucman-Rossi Jessica,Cagnot Carole,Ganne-Carrié Nathalie,Chaffaut Cendrine,Guyot Erwan^ORCID,Ziol Marianne^ORCID,Sutton Angela^ORCID,Audureau Etienne^ORCID,Nahon Pierre,Asselah Tarik,Guyader Dominique,Pol Stanislas,Fontaine Hélène,Pageaux Georges-Philippe,De Lédinghen Victor,Ouzan Denis,Zoulim Fabien,Roulot Dominique,Tran Albert,Bronowicki Jean-Pierre,Decaensi Thomas,Riachi Ghassan,Calès Paul,Péron Jean-Marie,Alric Laurent,Bourlière Marc,Mathurin Philippe,Dharancy Sebastien,Blanc Jean-Frédéric,Abergel Armand,Chazouillères Olivier,Mallat Ariane,Grangé Jean-Didier,Attali Pierre,Louis d’Alteroche ,Wartelle Claire,Dao Thông,Thabut Dominique,Pilette Christophe,Silvain Christine,Christidis Christos,Nguyen-Khac Eric,Bernard-Chabert Brigitte,Hillaire Sophie,Di Martino Vincent,Ganne-Carrié Nathalie,Chaffaut Cendrine,Archambeaud Isabelle,d’Alteroche Louis,Oberti Frédéric,Roulot Dominique,Moreno Christophe,Louvet Alexandre,Dao Thông,Moirand Romain,Goria Odile,Nguyen-Khac Eric,Carbonell Nicolas,Duclos-Vallée Jean-Charles,Pol Stanislas,de Ledinghen Victor,Ozenne Violaine,Henrion Jean,Péron Jean-Marie,Tran Albert,Perlemuter Gabriel,Amiot Xavier,Zarski Jean-Pierre,Chevret Sylvie

Publisher

Elsevier BV

Subject

Hepatology

Reference43 articles.

1. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis;Nahon;J Hepatol,2012

2. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease;Romeo;Nat Genet,2008

3. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease;Kozlitina;Nat Genet,2014

4. The rs429358 locus in apolipoprotein E is associated with hepatocellular carcinoma in patients with cirrhosis;Innes;Hepatol Commun,2022

5. A protein-truncating HSD17B13 variant and protection from chronic liver disease;Abul-Husn;New Engl J Med,2018

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Predictive Accuracy of the aMAP Risk Score for Hepatocellular Carcinoma (HCC): Diagnostic Test Accuracy and Meta-analysis;Journal of Clinical and Experimental Hepatology;2025-01

2. Appraising the causal effects of circulating micronutrients on liver cirrhosis: Evidence from large‐scale Mendelian randomization analysis;Portal Hypertension & Cirrhosis;2024-09-10

3. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma;Molecular Cancer;2024-09-06

4. Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs;Annals of Hepatology;2024-09

5. Metabolomics biomarkers of hepatocellular carcinoma in a prospective cohort of patients with cirrhosis;JHEP Reports;2024-08